280 related articles for article (PubMed ID: 8475548)
1. Risk factors for chronic rejection in renal allograft recipients.
Almond PS; Matas A; Gillingham K; Dunn DL; Payne WD; Gores P; Gruessner R; Najarian JS
Transplantation; 1993 Apr; 55(4):752-6; discussion 756-7. PubMed ID: 8475548
[TBL] [Abstract][Full Text] [Related]
2. Effect of early cyclosporine levels on kidney allograft rejection.
Johnson EM; Canafax DM; Gillingham KJ; Humar A; Pandian K; Kerr SR; Najarian JS; Matas AJ
Clin Transplant; 1997 Dec; 11(6):552-7. PubMed ID: 9408683
[TBL] [Abstract][Full Text] [Related]
3. Pediatric renal transplants--results with sequential immunosuppression.
Almond PS; Matas AJ; Gillingham K; Moss A; Mauer M; Chavers B; Nevins T; Kashtan C; Dunn D; Payne W
Transplantation; 1992 Jan; 53(1):46-51. PubMed ID: 1733084
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for chronic rejection in pediatric renal transplant recipients--a single-center experience.
Birk PE; Matas AJ; Gillingham KJ; Mauer SM; Najarian JS; Chavers BM
Pediatr Nephrol; 1997 Aug; 11(4):395-8. PubMed ID: 9260232
[TBL] [Abstract][Full Text] [Related]
5. Chronic allograft nephropathy uniformly affects recipients of cadaveric, nonidentical living-related, and living-unrelated grafts.
Krieger NR; Becker BN; Heisey DM; Voss BJ; D'Alessandro AM; Becker YT; Odorico JS; Kalayoglu M; Pirsch JD; Sollinger HW; Knechtle SJ
Transplantation; 2003 May; 75(10):1677-82. PubMed ID: 12777855
[TBL] [Abstract][Full Text] [Related]
6. Determinants of chronic renal allograft rejection in cyclosporine-treated recipients.
Flechner SM; Modlin CS; Serrano DP; Goldfarb DA; Papajcik D; Mastroianni B; Goormastic M; Novick AC
Transplantation; 1996 Nov; 62(9):1235-41. PubMed ID: 8932263
[TBL] [Abstract][Full Text] [Related]
7. Adult-size kidneys without acute tubular necrosis provide exceedingly superior long-term graft outcomes for infants and small children: a single center and UNOS analysis. United Network for Organ Sharing.
Sarwal MM; Cecka JM; Millan MT; Salvatierra O
Transplantation; 2000 Dec; 70(12):1728-36. PubMed ID: 11152105
[TBL] [Abstract][Full Text] [Related]
8. Evidence that improved late renal transplant outcome correlates with the development of in vitro donor antigen-specific hyporeactivity.
Reinsmoen NL; Matas AJ
Transplantation; 1993 May; 55(5):1017-23. PubMed ID: 7684534
[TBL] [Abstract][Full Text] [Related]
9. Chronic rejection in renal transplant recipients--risk factors and correlates.
Matas A
Clin Transplant; 1994 Jun; 8(3 Pt 2):332-5. PubMed ID: 8061376
[TBL] [Abstract][Full Text] [Related]
10. Variable cyclosporine exposure: a risk factor for chronic allograft nephropathy and graft loss?
He X; Johnston A
Transplant Proc; 2004 Jun; 36(5):1321-6. PubMed ID: 15251323
[TBL] [Abstract][Full Text] [Related]
11. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
[TBL] [Abstract][Full Text] [Related]
12. [Acute rejection in cadaveric renal transplantation under cyclosporine based therapy. Analysis of the risk factors and its influence on chronic dysfunction].
Mota A
Acta Med Port; 2004; 17(1):8-14. PubMed ID: 15636737
[TBL] [Abstract][Full Text] [Related]
13. Living unrelated donors in kidney transplants: better long-term results than with non-HLA-identical living related donors?
Humar A; Durand B; Gillingham K; Payne WD; Sutherland DE; Matas AJ
Transplantation; 2000 May; 69(9):1942-5. PubMed ID: 10830235
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for second renal allografts immunosuppressed with cyclosporine.
Almond PS; Matas AJ; Gillingham K; Troppmann C; Payne W; Dunn D; Sutherland D; Najarian JS
Transplantation; 1991 Aug; 52(2):253-8. PubMed ID: 1871798
[TBL] [Abstract][Full Text] [Related]
15. The impact of acute rejection episodes on long-term graft function and outcome in 1347 primary renal transplants treated by 3 cyclosporine regimens.
Lindholm A; Ohlman S; Albrechtsen D; Tufveson G; Persson H; Persson NH
Transplantation; 1993 Aug; 56(2):307-15. PubMed ID: 8356584
[TBL] [Abstract][Full Text] [Related]
16. Donor catecholamine use reduces acute allograft rejection and improves graft survival after cadaveric renal transplantation.
Schnuelle P; Lorenz D; Mueller A; Trede M; Van Der Woude FJ
Kidney Int; 1999 Aug; 56(2):738-46. PubMed ID: 10432416
[TBL] [Abstract][Full Text] [Related]
17. The adverse impact of cytomegalovirus infection on clinical outcome in cyclosporine-prednisone treated renal allograft recipients.
Lewis RM; Johnson PC; Golden D; Van Buren CT; Kerman RH; Kahan BD
Transplantation; 1988 Feb; 45(2):353-9. PubMed ID: 2830686
[TBL] [Abstract][Full Text] [Related]
18. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
Shabtai M; Ben-Haim M; Zemer D; Malinger-Saavedra P; Rosin D; Kuriansky J; Lustig S; Shabtai EL; Shapira Z; Ayalon A
Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
[TBL] [Abstract][Full Text] [Related]
19. Impact of the variability of cyclosporin A trough levels on long-term renal allograft function.
Waiser J; Slowinski T; Brinker-Paschke A; Budde K; Schreiber M; Böhler T; Hauser I; Neumayer HH
Nephrol Dial Transplant; 2002 Jul; 17(7):1310-7. PubMed ID: 12105257
[TBL] [Abstract][Full Text] [Related]
20. Chronic allograft dysfunction in kidney transplant recipients: long-term single-center study.
Boratyńska M; Wakulenko A; Klinger M; Szyber P
Transplant Proc; 2014 Oct; 46(8):2673-7. PubMed ID: 25380892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
